Literature DB >> 32417198

Assisted reproductive technology in Latin America: the Latin American Registry, 2017.

Fernando Zegers-Hochschild1, Javier A Crosby2, Carolina Musri2, Maria do Carmo Borges de Souza3, A Gustavo Martinez4, Adelino Amaral Silva5, José María Mojarra6, Diego Masoli2, Natalia Posada7.   

Abstract

RESEARCH QUESTION: What was the utilization, effectiveness and safety of assisted reproductive technologies (ART) carried out in Latin America during 2017.
DESIGN: Retrospective collection of multinational data on ART carried out in 188 institutions from 15 Latin American countries.
RESULTS: In this study, 93,600 initiated cycles, 16,976 deliveries and 20,404 births reported. Utilization of ART was 221 cycles per million inhabitants (15 to 535). Women aged 40 years and above represented 30.5% of fresh IVF and intracytoplasmic sperm injection (ICSI); however, after removing freeze-all cycles, delivery rate per oocyte retrieval was 19.9% for ICSI and 20.2% for IVF. Overall, single embryo transfer (SET) represented 26.9% of fresh transfers, with 18.2% delivery rate per transfer, increasing to 32.3% in elective SET. Delivery rate in double embryo transfers (DET) was 28.3% increasing to 37.3% with elective DET. This 5% increment in births in elective DET over elective SET resulted in a tenfold increase in twin births, gestational periods almost 3 weeks' shorter and a threefold increase in perinatal mortality. Delivery rate in frozen-thawed SET reached 25.5% increasing to 30.8% with DET, most being blastocyst transfers. Of all births, 66.9% were singletons, 31.4% twins and 1.6% triplets and higher. Overall, preterm deliveries reached 9.5% in singletons, 64.3% in twins and 97.9% in triplets; perinatal mortality was 9.4‰ in singletons, 25.3‰ in twins and 63.3‰ in high-order multiples.
CONCLUSIONS: The number of initiated cycles has slowly increased. Frozen embryo transfers, blastocyst transfers and SET are also increasing. Our data show that, especially in young women and oocyte recipients, when there is more than one blastocyst for transfer, elective SET should be the rule.
Copyright © 2020 Reproductive Healthcare Ltd. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  ART utilization; Assisted reproductive technology; Latin American Registry; Perinatal outcome; Success rates

Mesh:

Year:  2020        PMID: 32417198     DOI: 10.1016/j.rbmo.2020.02.004

Source DB:  PubMed          Journal:  Reprod Biomed Online        ISSN: 1472-6483            Impact factor:   3.828


  5 in total

1.  20 years of the European IVF-monitoring Consortium registry: what have we learned? A comparison with registries from two other regions.

Authors:  Ch De Geyter; C Wyns; C Calhaz-Jorge; J de Mouzon; A P Ferraretti; M Kupka; A Nyboe Andersen; K G Nygren; V Goossens
Journal:  Hum Reprod       Date:  2020-12-01       Impact factor: 6.918

2.  Results of Preimplantation Genetic Testing for Aneuploidy (PGT-A) in a Cohort of 319 Embryos: Experience in a Fertility Clinic in Colombia.

Authors:  Germán David Ospina Idárraga; Iván Darío Montes Suárez; Katherine Gisell Hernández Osorio; Diana Milena Diaz Corredor; Johanna Carolina Páez Redondo; Ricardo Garcia Yepes
Journal:  JBRA Assist Reprod       Date:  2022-04-17

3.  Assisted Reproductive Technologies in the Republic of Kazakhstan: A 6-Year Trend Analysis from Efficacy to Availability.

Authors:  Vyacheslav Lokshin; Meruyert Omar; Sholpan Karibaeva
Journal:  J Reprod Infertil       Date:  2022 Jan-Mar

4.  Celebrating 30 years of ART in Latin America; and the 2018 report.

Authors:  Fernando Zegers-Hochschild; Javier A Crosby; Carolina Musri; Maria do Carmo Borges de Souza; A Gustavo Martínez; Adelino Amaral Silva; José María Mojarra; Diego Masoli; Natalia Posada
Journal:  JBRA Assist Reprod       Date:  2021-10-04

5.  Calcium Ionophore (A23187) Rescues the Activation of Unfertilized Oocytes After Intracytoplasmic Sperm Injection and Chromosome Analysis of Blastocyst After Activation.

Authors:  Ziwen Xu; Guidong Yao; Wenbin Niu; Huiying Fan; Xueshan Ma; Senlin Shi; Haixia Jin; Wenyan Song; Yingpu Sun
Journal:  Front Endocrinol (Lausanne)       Date:  2021-07-15       Impact factor: 5.555

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.